ARCHIVES

FDA Commissioner Says Swifter Drug Approvals, Enforcement Emphasis Characterize ‘Today’s FDA’

This article is from The Cancer Letter archive.

Vol. 18 No. 05 | January 31, 1992

Download PDF Visit The Full Archive

Related Articles

Afinitor Approved for Rare Disorder

November 5, 2010

In Brief: Innovative Antismoking Efforts Needed, CCRAC Told, Illinois To Go After Neutron Contract

December 8, 1978

FDA Official Says Acceptance of PFS “Brings Us In Line With Our European Colleagues.”

July 21, 2006

Turmoil in Texas: SEC Issues Subpoena to AVEO on Tivozanib

July 12, 2013

Amgen Pays $24.9 Million To Settle Kickback Charges

April 19, 2013

Oxaliplatin Regimen May Beat Standard For Advanced Colorectal Cancer, NCI Says

April 26, 2002